chr9-101433826-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000035.4(ALDOB):​c.-11+1883G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.631 in 151,800 control chromosomes in the GnomAD database, including 30,673 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.63 ( 30673 hom., cov: 30)

Consequence

ALDOB
NM_000035.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -3.65

Publications

2 publications found
Variant links:
Genes affected
ALDOB (HGNC:417): (aldolase, fructose-bisphosphate B) Fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) is a tetrameric glycolytic enzyme that catalyzes the reversible conversion of fructose-1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. Vertebrates have 3 aldolase isozymes which are distinguished by their electrophoretic and catalytic properties. Differences indicate that aldolases A, B, and C are distinct proteins, the products of a family of related 'housekeeping' genes exhibiting developmentally regulated expression of the different isozymes. The developing embryo produces aldolase A, which is produced in even greater amounts in adult muscle where it can be as much as 5% of total cellular protein. In adult liver, kidney and intestine, aldolase A expression is repressed and aldolase B is produced. In brain and other nervous tissue, aldolase A and C are expressed about equally. There is a high degree of homology between aldolase A and C. Defects in ALDOB cause hereditary fructose intolerance. [provided by RefSeq, Dec 2008]
ALDOB Gene-Disease associations (from GenCC):
  • hereditary fructose intolerance
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Myriad Women’s Health, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.679 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000035.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALDOB
NM_000035.4
MANE Select
c.-11+1883G>A
intron
N/ANP_000026.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALDOB
ENST00000647789.2
MANE Select
c.-11+1883G>A
intron
N/AENSP00000497767.1
ALDOB
ENST00000648064.1
c.-10-2929G>A
intron
N/AENSP00000497990.1
ALDOB
ENST00000648758.1
c.-10-2929G>A
intron
N/AENSP00000497731.1

Frequencies

GnomAD3 genomes
AF:
0.631
AC:
95697
AN:
151682
Hom.:
30658
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.562
Gnomad AMI
AF:
0.473
Gnomad AMR
AF:
0.647
Gnomad ASJ
AF:
0.694
Gnomad EAS
AF:
0.535
Gnomad SAS
AF:
0.479
Gnomad FIN
AF:
0.626
Gnomad MID
AF:
0.756
Gnomad NFE
AF:
0.685
Gnomad OTH
AF:
0.669
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.631
AC:
95756
AN:
151800
Hom.:
30673
Cov.:
30
AF XY:
0.626
AC XY:
46410
AN XY:
74180
show subpopulations
African (AFR)
AF:
0.563
AC:
23269
AN:
41358
American (AMR)
AF:
0.647
AC:
9877
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.694
AC:
2409
AN:
3470
East Asian (EAS)
AF:
0.535
AC:
2737
AN:
5118
South Asian (SAS)
AF:
0.479
AC:
2298
AN:
4798
European-Finnish (FIN)
AF:
0.626
AC:
6603
AN:
10542
Middle Eastern (MID)
AF:
0.755
AC:
222
AN:
294
European-Non Finnish (NFE)
AF:
0.685
AC:
46513
AN:
67940
Other (OTH)
AF:
0.662
AC:
1397
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1740
3480
5221
6961
8701
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
778
1556
2334
3112
3890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.646
Hom.:
3951
Bravo
AF:
0.633
Asia WGS
AF:
0.498
AC:
1730
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.071
DANN
Benign
0.23
PhyloP100
-3.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs970385; hg19: chr9-104196108; API